Clinical Trial Update: the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamic effects of a therapy aimed at lowering LDL-C in adults with elevated LDL-C.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: Shanghai Rona Therapeutics Co., Ltd. | Conditions: To Reduce the LDL-C Level in Hypercholesteremia Patients | Phase 1 | Status: COMPLETED